Status:
NOT_YET_RECRUITING
Genetics of Neonatal Encephalopathy and Related Disorders
Lead Sponsor:
Boston Children's Hospital
Conditions:
Neonatal Encephalopathy
Hypoxic Ischaemic Encephalopathy (HIE)
Eligibility:
All Genders
Brief Summary
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These ...
Detailed Description
Neonatal encephalopathy (NE) is a disorder of term newborns involving dysfunction of the central nervous system and can impact one's health throughout the lifespan. While NE can be caused by a number ...
Eligibility Criteria
Inclusion
- Proband Criteria:
- Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record
- Less than 6 years old at the time of study enrollment
- Patient at Boston Children's Hospital
Exclusion
- Genetic cause of NE already identified
- Deceased prior to enrollment
- Parent criteria:
- Inclusion Criteria:
- \- Biological parent of eligible proband (see above)
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2035
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07165938
Start Date
October 1 2025
End Date
September 1 2035
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115